Poland
University studies- MSc, biotechnology Where it began — molecular biology, microbiology, bioprocesses. À compléter : nom de l’université et années.
PhD · Physiology & Pathophysiology (FR) · MSc Toxicology (AT) · MSc Biotechnology (PL) · ICF ACC (UK)
A.R.C. → E² : Experiment × Enjoy → Energy
I work at the precise point where working conditions meet human biology. Twenty years establishing how an exposure with hazard becomes an effect — and now, how a condition becomes a capacity.
20years in science In academia, european institutions and industry
7countires professional adress
5Languages
2Marie Curie fellowships
1patent, WO 2021/148661
The path
Twenty years tracing causal chains.
I spent my scientific career establishing how an exposure becomes an effect: by which mechanism, at what dose, with what uncertainty. In regulatory toxicology that discipline has a name — Adverse Outcome Pathways. You learn to separate what is demonstrated, what is plausible, and what is only a story.
When I moved into psychosocial risk, I found the same questions — and often, none of that discipline. That gap is the reason this company exists.
- A correlation is not a link. Every arrow is defended separately: biological plausibility, temporal coherence, dose–response, reproducibility. An arrow you cannot defend is removed, even when it made the story prettier.
- Uncertainty is declared. “this point is weak” does not weaken the work. It is what makes it usable.
- The level of organisation matters. A molecular effect is not a cellular effect, which is not an effect on the organism. Confusing the levels is the most common error in health communication.
Two domains, one through-line
Gut microbiota and regulatory toxicology.
They look unrelated. They are joined by nuclear receptor biology — the PPAR family runs through both halves of my published record.
Domain one
Host–microbiota molecular crosstalk
How commensal bacteria and their metabolites speak to the human intestinal epithelium: butyrate and short-chain fatty acid signalling, functional metagenomics, high-throughput reporter screening of NF-κB, AP-1 and PPARγ, and the muropeptide transporter published in PNAS in 2023.
INRAE / MICALIS · Karolinska Institutet
Domain two
Regulatory toxicology and alternatives to animal testing
Adverse Outcome Pathway development and best practice, the PPARα-activation and reproductive toxicity pathway, endocrine disruptor screening methodology, and non-animal safety assessment case studies.
European Commission JRC / EURL ECVAM · Unilever SEAC · Bayer Crop Science
The inversion
Why do we only have this tool for damage?
We know how to map, with precision, how a system goes from a trigger to a harm. We have nothing equivalent for mapping how it climbs back. Almost all of the self-improvement literature works by general assertion — do this, you will feel better — without ever specifying by what mechanism, at what level of organisation, with what degree of confidence.
The Empowerment Outcome Pathway™ is that inversion: the same causal logic and the same traceability, applied to recovery rather than to damage. In practice it produces three things — an explicit map of what triggers what in your system, the leverage points inside that chain, and a declared confidence level for every recommendation.
This is the work I am building now: linking adverse outcome pathways and the microbiome to empowered pathways.
Track record · 2006 – today
Seven countries. Five sectors. One evidence standard.
Academic research, an intergovernmental agency, an EU institution, industry — and now an independent practice and an association. The line beside each post carries the colours of that country’s flag.
- Academic research
- Industry
- Intergovernmental · UN system
- EU institution
- Association
- Entrepreneurship
Austria
Wien · Vienna- Universität für Bodenkultur Wien Erasmus exchange À compléter : années de l’échange Erasmus.
- International Atomic Energy Agency Research intern
Greece
Athens- National Hellenic Research Foundation Marie Curie fellowship À confirmer : nom exact de l’institut, intitulé du poste, années.
France
Paris-Saclay · Sophia Antipolis- INRAE, Micalis Institute Marie Curie fellowship — host–microbiota crosstalk
- Bayer Crop Science Regulatory toxicologist · R&D project lead
- ENENCORPS — Mon Corps, Mon Équipe Founder · body-literacy association for children aged 6–11 (RNA W061018413)
- Resilient by Design™ Scientist · independent consultant · ICF Coach
Sweden
Stockholm- Karolinska Institutet Doctoral exchange researcher
Italy
Ispra- European Commission, Joint Research Centre Scientific officer — EURL ECVAM
United Kingdom
Colworth Science Park- Unilever — Safety & Environmental Assurance Centre Risk assessor · regulatory innovation lead
Credentials
What the titles actually mean.
Listed here so you can check them, not to decorate the page.
- PhD, physiology and physiopathology. Plus an MSc in toxicology.
- European Registered Toxicologist. A peer-reviewed professional registration, renewed on evidence of continuing practice.
- ICF ACC coach. Certified August 2025, with 120 logged coaching hours.
- Registered IPRP with DREETS PACA. The French register of intervenants in occupational risk prevention.
- Marie Skłodowska-Curie fellow, twice. EURODESY 2009 and the Cross-Talk ITN 2012.
- Member, Marie Curie Alumni Association.
- Working languages. English, français, polski, italiano, Deutsch.
Next step
Three pilot teams this year.
Twenty-five minutes to check whether this format answers a real problem at your organisation. If it doesn’t, I’ll say so.